Prepyloric Ulcer: Symptoms, Causes, & Treatment

Translate to Spanish or other 102 languages!

Prepyloric ulcers are a type of peptic or gastric ulcer. These open sores develop in the upper digestive tract, just above the pylorus, which is the opening to the small intestine. Image for illustration purposes
Prepyloric ulcers are a type of peptic or gastric ulcer. These open sores develop in the upper digestive tract, just above the pylorus, which is the opening to the small intestine. Image for illustration purposes

Medical News Today

- Advertisement -

Prepyloric ulcers are a type of peptic or gastric ulcer. These open sores develop in the upper digestive tract, just above the pylorus, which is the opening to the small intestine. 

The tissues of the digestive system have natural defenses against acidic digestive fluids. However, certain factors can undermine these natural defenses, damaging the mucosal lining and causing ulcers. Damaging factors include bacterial infection, taking certain medications, and smoking.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/prepyloric-ulcer?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-07-05&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -